The Agenda
Agenda – What’s on when
7:00 – 7:55
Registration and Check-in Light Breakfast Served
7:55 – 8:00
Genomic Workshop – Welcome and Learning Objectives
Scientific Program Committee

Maher Albitar, MD, Genomic Testing Cooperative

Gustavo Rivero, MD, Tampa General Hospital Cancer Institute

Anne Renteria MD, New York University

David Swoboda, MD, Tampa General Hospital Cancer Institute
8:00 – 9:00
Keynotes
Session Chair Introduction
8:00-8:15
8:15-8:30
8:30-8:50
9:00 – 10:00
Session 1: Evolution into Myeloid Leukemogenesis
Session Chair Introduction

Gustavo Rivero, MD, Tampa Genral Hospital Cancer Institute
9:00-9:20

Gustavo Rivero, MD, Tampa Genral Hospital Cancer Institute
9:20-9:50

Maher Albitar, MD, Genomic Testing Cooperative

David Swoboda, MD, TGH Cancer Institute
9:50-10:00

Maher Albitar, MD, Genomic Testing Cooperative

David Swoboda, MD, TGH Cancer Institute
10:00-10:15
Coffee Break
10:15-11:30
Session 2: Myelodysplastic Syndrome
Session Chair Introduction

David Sallman, MD, Moffitt Cancer Center, University of South Florida
10:15-10:40

David Sallman, MD, Moffitt Cancer Center, University of South Florida
10:40-11:00

Gustavo Rivero, MD, Tampa General Hospital Cancer Institute
11:00-11:30

David Swoboda, MD, Tampa General Hospital Cancer Institute
11:30-11:55
Lunch is being combined with the combined with the product theater below
11:55-12:40
Product Theater – The Actionable MDS Genome-Telomerase Inhibitors
13:00 – 14:00
Session 3: Myeloproliferative Neoplasm
Session Chair Introduction
13:00-13:30
13:30-14:00
14:00-14:10
Coffee Break
14:10-15:10
Session 4: Lymphomas
Session Chair Introduction
14:10-14:40
14:40-15:00
15:00-16:00
Session 5: Multiple Myeloma
Session Chair Introduction
15:00-15:20
15:20-15:40
15:40-16:00
Saturday – May 17, 2025
7:00-7:55
Registration and Check-in Light Breakfast
7:55-8:00
8:00 – 8:20
Featured Lecture
Session Chair Introduction

Gustavo Rivero, MD, Tampa General Hospital Cancer Institute, Tampa, FL
8:00-8:20

Tiphaine Martin, MEg, PhD, Icahn School of Medicine at Mount Sinai
8:20-9:20
Session 1: Implementing a Clonal Hematopoiesis Clinic
Session Chair Introduction

Gustavo Rivero, MD, Tampa General Hospital Cancer Institute
8:20-8:40
8:40-9:00
9:00-9:20
9:20-10:20
Session 2: Myelodysplastic Syndrome
Session Chair Introduction
9:20-9:40
9:40-10:00
10:00-10:20

David Sallman, MD, Moffitt Cancer Center, University of South Florida
10:30-11:30
Session 3: Racial Disparity and Myeloid Malignancies
Session Chair Introduction

Gustavo Rivero, MD, Tampa General Hospital Cancer Institute
10:30-10:50
10:50-11:10

Lacey Williams, MD, University of North Carolina
11:10-11:30
11:30-11:45
Lunch – This is being combined with the TGH Cancer Institute Sponsored Session Below 11:45-13:00
11:45 – 13:00
Tampa General Hospital Cancer Institute Sponsored Session:
HTLV from Discovery to Genomics
Session Co-Chairs

Gustavo Rivero, MD, Tampa General Hospital Cancer Institute
11:45-12:10
12:10-12:35
12:35-13:00
13:00-15:25
Session 4: AML Highlights – What Physicians Should Know
Session Chair Introduction

David Swoboda, MD, Tampa General Hospital Cancer Institute
13:00-13:25

Jonathan Licht, MD, University of Florida Health Cancer Center
13:25-13:50

Manja Meggendorfer, PhD, Munich Leukemia Laboratory
13:50-14:10

David Swoboda, MD, Tampa General Hospital Cancer Institute
14:10-14:30

Jeffrey Lancet, MD, Lee Moffitt Cancer Center, Tampa
14:30-14:50

Sergio Rutella, MD, Nottingham University, United Kingdom
14:50-15:15
Coffee Break
15:15-16:35
Session 5: Cellular Therapy
Session Chair Introduction
15:15-14:35
15:35-15:55
15:55-16:15
16:15-16:35
16:35-16:45